172.57
price down icon2.94%   -5.22
after-market Handel nachbörslich: 172.57
loading

Belite Bio Inc Adr Aktie (BLTE) Neueste Nachrichten

pulisher
Mar 04, 2026

H.C. Wainwright raises Belite Bio stock price target on NDA timeline - Investing.com Nigeria

Mar 04, 2026
pulisher
Mar 04, 2026

Mizuho reiterates Belite Bio stock rating on NDA timeline update - Investing.com Nigeria

Mar 04, 2026
pulisher
Mar 04, 2026

Belite Bio Q4 Earnings Call Highlights - Defense World

Mar 04, 2026
pulisher
Mar 04, 2026

Belite Bio (NASDAQ:BLTE) Given New $266.00 Price Target at Cantor Fitzgerald - Defense World

Mar 04, 2026
pulisher
Mar 03, 2026

Belite Bio (NASDAQ:BLTE) Price Target Raised to $200.00 at HC Wainwright - MarketBeat

Mar 03, 2026
pulisher
Mar 03, 2026

Belite Bio (BLTE) Q4 2025 Earnings Call Transcript - The Globe and Mail

Mar 03, 2026
pulisher
Mar 03, 2026

Belite Bio (NASDAQ:BLTE) Price Target Raised to $201.00 - MarketBeat

Mar 03, 2026
pulisher
Mar 03, 2026

Belite Bio stock price target raised to $217 by Benchmark on trial data - Investing.com

Mar 03, 2026
pulisher
Mar 03, 2026

Belite Bio (NASDAQ:BLTE) Price Target Raised to $266.00 at Cantor Fitzgerald - MarketBeat

Mar 03, 2026
pulisher
Mar 03, 2026

Cantor Fitzgerald raises Belite Bio stock price target on pricing outlook - Investing.com

Mar 03, 2026
pulisher
Mar 02, 2026

Earnings call transcript: Belite Bio beats Q4 2025 EPS expectations, stock dips slightly - Investing.com India

Mar 02, 2026
pulisher
Mar 02, 2026

Belite Bio (NASDAQ:BLTE) Shares Down 8.6%What's Next? - MarketBeat

Mar 02, 2026
pulisher
Mar 02, 2026

Belite Bio to Participate in the Leerink Global Healthcare Conference - wjfw.com

Mar 02, 2026
pulisher
Mar 02, 2026

Belite Bio Posts 2025 Results as Tinlarebant Nears NDA Filing After Phase 3 Win - TipRanks

Mar 02, 2026
pulisher
Mar 02, 2026

Belite Bio Reports Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update - The Globe and Mail

Mar 02, 2026
pulisher
Feb 27, 2026

Stargardt Disease Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | Ocugen, Kubota Vision Inc, Nanoscope Therapeutics, RBP4 Pty Ltd, Stargazer Pharma, Belite Bio, Alkeus Pharma - Barchart.com

Feb 27, 2026
pulisher
Feb 27, 2026

Exploring Belite Bio's Earnings Expectations - Sahm

Feb 27, 2026
pulisher
Feb 23, 2026

Liquidity Mapping Around (BLTE) Price Events - Stock Traders Daily

Feb 23, 2026
pulisher
Feb 23, 2026

Belite Bio to Host Webcast on March 2, 2026, to Discuss Preliminary, Unaudited Fourth Quarter ... - Caledonian Record

Feb 23, 2026
pulisher
Feb 22, 2026

China Universal Asset Management Co. Ltd. Acquires New Position in Belite Bio, Inc. Sponsored ADR $BLTE - Defense World

Feb 22, 2026
pulisher
Feb 20, 2026

Belite Bio (NASDAQ:BLTE) Shares Gap UpStill a Buy? - MarketBeat

Feb 20, 2026
pulisher
Feb 17, 2026

Belite Bio, Inc (BLTE) Stock Report: Analyst Ratings Signal Strong Buy with 9.62% Potential Upside - DirectorsTalk Interviews

Feb 17, 2026
pulisher
Feb 17, 2026

Darwin Global discloses 8.1% Belite Bio (BLTE) holding in 13G/A - Stock Titan

Feb 17, 2026
pulisher
Feb 16, 2026

Belite Bio, Inc. Sponsored ADR (NASDAQ:BLTE) Sees Large Growth in Short Interest - Defense World

Feb 16, 2026
pulisher
Feb 15, 2026

Belite Bio, Inc. Sponsored ADR (NASDAQ:BLTE) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat

Feb 15, 2026
pulisher
Feb 14, 2026

Belite Bio, Inc. Sponsored ADR (NASDAQ:BLTE) Short Interest Up 49.4% in January - MarketBeat

Feb 14, 2026
pulisher
Feb 12, 2026

Why (BLTE) Price Action Is Critical for Tactical Trading - Stock Traders Daily

Feb 12, 2026
pulisher
Feb 10, 2026

Belite Bio, Inc (BLTE) Stock Analysis: Biotechnology Innovator With 4.98% Potential Upside - DirectorsTalk Interviews

Feb 10, 2026
pulisher
Feb 09, 2026

Belite Bio (NASDAQ:BLTE) Shares Down 5.2%Here's Why - MarketBeat

Feb 09, 2026
pulisher
Feb 09, 2026

Belite Bio (BLTE) Valuation Check After Completing Enrollment In Pivotal DRAGON II Trial - Sahm

Feb 09, 2026
pulisher
Feb 03, 2026

Belite Bio stock hits all-time high at 177.28 USD By Investing.com - Investing.com Nigeria

Feb 03, 2026
pulisher
Feb 03, 2026

Belite Bio stock hits all-time high at 177.28 USD - Investing.com

Feb 03, 2026
pulisher
Feb 03, 2026

Belite Bio (NASDAQ:BLTE) Reaches New 12-Month HighHere's What Happened - MarketBeat

Feb 03, 2026
pulisher
Feb 01, 2026

Belite Bio (BLTE) Valuation Check As Phase 3 DRAGON Tinlarebant Data Presentations Approach - Sahm

Feb 01, 2026
pulisher
Feb 01, 2026

Understanding Momentum Shifts in (BLTE) - Stock Traders Daily

Feb 01, 2026
pulisher
Jan 29, 2026

Belite Bio Announces Participation at the 41st Asia-Pacific Academy of Ophthalmology Congress (APAO) - markets.businessinsider.com

Jan 29, 2026
pulisher
Jan 28, 2026

H.C. Wainwright reiterates Buy rating on Belite Bio stock with $185 target By Investing.com - Investing.com South Africa

Jan 28, 2026
pulisher
Jan 28, 2026

H.C. Wainwright reiterates Buy rating on Belite Bio stock with $185 target - Investing.com Nigeria

Jan 28, 2026
pulisher
Jan 28, 2026

Belite Bio's (BLTE) Buy Rating Reiterated at HC Wainwright - MarketBeat

Jan 28, 2026
pulisher
Jan 27, 2026

Belite Bio completes enrollment in phase 2/3 STGD1 drug trial - Investing.com India

Jan 27, 2026
pulisher
Jan 27, 2026

Belite Bio Completes Global Enrollment in DRAGON II Tinlarebant Trial for Stargardt Disease - TipRanks

Jan 27, 2026
pulisher
Jan 27, 2026

Belite Bio (NASDAQ:BLTE) Now Covered by Bank of America - Defense World

Jan 27, 2026
pulisher
Jan 26, 2026

Belite Bio (NASDAQ:BLTE) Reaches New 1-Year HighStill a Buy? - MarketBeat

Jan 26, 2026
pulisher
Jan 26, 2026

Belite Bio Surges on Breakthrough Eye Drug Hopes - TipRanks

Jan 26, 2026
pulisher
Jan 26, 2026

Belite Bio stock hits all-time high at $170.35 - Investing.com

Jan 26, 2026
pulisher
Jan 26, 2026

Belite Bio stock hits all-time high at $170.35 By Investing.com - Investing.com UK

Jan 26, 2026
pulisher
Jan 26, 2026

BofA Securities initiates coverage on Belite Bio stock with Buy rating - Investing.com Canada

Jan 26, 2026
pulisher
Jan 26, 2026

BofA Securities initiates coverage on Belite Bio stock with Buy rating By Investing.com - Investing.com South Africa

Jan 26, 2026
pulisher
Jan 23, 2026

Stargardt Disease Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Nanoscope Therapeutics, Belite Bio, Biophytis, reVision Therapeutics - Barchart.com

Jan 23, 2026
pulisher
Jan 21, 2026

Avoiding Lag: Real-Time Signals in (BLTE) Movement - Stock Traders Daily

Jan 21, 2026
$45.68
price down icon 3.69%
$53.83
price down icon 6.87%
$29.72
price up icon 0.68%
$101.95
price down icon 1.78%
$143.54
price down icon 4.23%
biotechnology ONC
$292.94
price down icon 2.03%
Kapitalisierung:     |  Volumen (24h):